SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-057002
Filing Date
2020-12-14
Accepted
2020-12-14 16:26:14
Documents
14
Period of Report
2020-12-11
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K odt-8k_20201211.htm   iXBRL 8-K 34934
2 EX-99.1 odt-ex991_6.htm EX-99.1 26471
3 GRAPHIC gqvi5j4c0k1j000001.jpg GRAPHIC 3585
  Complete submission text file 0001564590-20-057002.txt   205905

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA odt-20201211.xsd EX-101.SCH 5769
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE odt-20201211_lab.xml EX-101.LAB 20214
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE odt-20201211_pre.xml EX-101.PRE 12079
7 EXTRACTED XBRL INSTANCE DOCUMENT odt-8k_20201211_htm.xml XML 3685
Mailing Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121 858-200-3830
Odonate Therapeutics, Inc. (Filer) CIK: 0001717452 (see all company filings)

IRS No.: 822493065 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38318 | Film No.: 201386473
SIC: 2834 Pharmaceutical Preparations